P21: What the Research Actually Shows

← Back to Research Library
Research Library · Cognitive

P21 (P021): What the Research Actually Shows

At a Glance
  • What it is: A small synthetic peptide, four amino acids long, modeled on a piece of a natural nerve-growth signal called CNTF and first pulled out of the mix in Cerebrolysin.
  • Researchers have studied it for: new nerve-cell growth (neurogenesis), memory in aging and Alzheimer-model mice, and tau and amyloid changes in those same models.
  • Evidence level: Preclinical only. Cell dishes and mice. No published human trials.
  • The short version: Researchers built P21 to copy part of a natural nerve-growth signal, then ran it through mice and cell models. In those models they watched for more new neurons, more BDNF, and better memory scores. The human case has not been tested. This is a summary of research, not a description of what P21 does for you.

P21 (also written P021 or P-21) is a small synthetic peptide first identified from Cerebrolysin, a mix of nerve-signal fragments, and shaped in the lab to copy the active region of a natural growth signal called CNTF. Researchers have studied it almost entirely in mice and cell dishes, and the published human evidence is zero, so this page stays honest about how thin the record is.

Here is the honest version. Below is what researchers looked at, in what kind of model, and what they observed. We are telling you what researchers found, not what it does for you.

What researchers have studied

The first mouse study (Li, FEBS Letters, 2010). An animal study in normal adult mice, not people. Researchers gave the peptide (they called it P21, Ac-DGGLAG-NH2) by peripheral dosing and reported better scores on learning, short-term memory, and spatial memory. They also observed more new neurons forming and maturing in the dentate gyrus, a memory region of the brain. This is the foundational P21 paper, and it is a mouse study. PMID 20600002. https://pubmed.ncbi.nlm.nih.gov/20600002/

Alzheimer-model mice (Kazim, Neurobiology of Disease, 2014). An animal study in 3xTg-AD mice, a strain bred to build Alzheimer-like pathology. Researchers fed P021 orally for 12 months starting at 9 to 10 months of age. They reported lower abnormal tau and lower soluble amyloid-beta, along with rescued deficits in cognition, neurogenesis, and synaptic plasticity, and they tied the effect to higher BDNF and reduced GSK3beta activity. Live animal model, not human. PMID 25046994. https://pubmed.ncbi.nlm.nih.gov/25046994/

Mechanism review (Kazim and Iqbal, Molecular Neurodegeneration, 2016). A review, not new data. The authors pulled together the work on CNTF small-molecule mimetics as a possible Alzheimer’s approach and described P021 as a compound that raises BDNF, blocks a signal called LIF, and lowers GSK3beta activity in research models. This is an interpretation of prior studies, not an experiment. PMID 27400746. https://pubmed.ncbi.nlm.nih.gov/27400746/

A model that did not deliver in the live animal (Mottolese, Journal of Neurodevelopmental Disorders, 2024). A study using both cell cultures and Cdkl5 knockout mice, a model of CDKL5 deficiency disorder. In the dish, researchers reported P021 restored neuron proliferation, survival, and maturation. But in the live mice, chronic oral P021 failed to raise BDNF and did not fix the brain defects, with only limited behavior change. A useful honest data point: what worked in the dish did not carry into the animal here. PMID 39592934. https://pubmed.ncbi.nlm.nih.gov/39592934/

How it works

CNTF is a natural signal the body uses to support nerve cells. P21 is a four-amino-acid fragment modeled on the active region of that signal, with an adamantane group bolted on so it survives the gut and crosses into the brain.

In the models above, researchers describe two connected moves. First, the peptide blocks a signal called LIF and raises BDNF, a growth factor tied to new-neuron formation and memory. Second, that higher BDNF appears to lower the activity of GSK3beta, an enzyme linked to the tau tangles seen in the Alzheimer models.

The honest part: this whole chain comes from mice and cells in a dish. No single step has been confirmed in a person, and one of the studies above showed the effect can drop out entirely when you move from the dish to the live animal.

What the research does not establish

  • There is no human data at all. Every finding above is a mouse study or a cell dish. Zero published human trials.
  • What happens in a mouse or a dish does not tell you what happens in a person. One study here showed that gap directly.
  • There is no approved use. P21 is not an FDA-approved drug and has not been shown to work in healthy people for memory, focus, or aging.
  • Much of the strongest work traces back to one research group, so independent replication is still light.
  • Nothing here is a safety conclusion, and this is not a claim that the compound is safe to use.
  • This page is a research summary only. It does not say the compound does anything “for you.”

Anyone selling you a settled human story on P21 is way out ahead of the science.

For Research Use Only. Not for human consumption. Etched Research supplies compounds for laboratory and research use only. Independent identity and purity testing by Janoshik. Nothing on this page is medical advice, a health claim, or a recommendation to use.

Available at Etched Research
Research-grade material, batch COA included. For research use only.
View product →
Scroll to Top